Sign in
Taking people in United StatesNo phase

Follows pregnant women taking pitolisant for narcolepsy and their babies

Tracks health of pregnant women using pitolisant, and their children.

Key facts

Who runs it
Harmony Biosciences Management, Inc.
Where
Morrisville, United StatesSee the site
Trial code
Registry title
WAKIX® (Pitolisant) Pregnancy Registry
Status
Recruiting
People taking part
1,329 people, planned
Started
24 Aug 2021
Expected to end
30 Jun 2030
Type of study
Observational, 5 groups
Treatments tested
  • Pitolisant
  • Comparator Products
Record updated
12 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women in the US, with or without narcolepsy, to study how pitolisant use during pregnancy affects mothers and babies. It only observes; it gives no treatment.

Age
Any age.
Sex
Women only (pregnant women).
Disease stage
Women with narcolepsy (a sleep disorder) can join. Women without narcolepsy can join if they took pitolisant or a comparator product during pregnancy.
Earlier treatment
Women with narcolepsy can join if they had at least one dose of pitolisant or a comparator product during pregnancy, or neither. Women without narcolepsy must have had at least one dose of pitolisant or a comparator product during pregnancy.

Main reasons for not taking part

  • The pregnancy already ended before first contact with the Registry Coordination Center.

This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant woman of any age

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Pregnant woman of any age
  • Consent to participate
  • Authorization for her HCP(s) to provide data to the registry
  • For participants with a diagnosis of narcolepsy: exposure to at least one dose of pitolisant or one dose of a comparator product, or, unexposed to pitolisant or comparator products at any time during pregnancy (i.e., any pregnant woman with a diagnosis of narcolepsy)
  • For participants without a diagnosis of narcolepsy: exposure to at least one dose of pitolisant or one dose of a comparator product at any time during pregnancy; Exclusion Criterion:
  • Occurrence of pregnancy outcome prior to first contact with the Registry Coordination Center (RCC) (i.e., retrospectively enrolled)

Where in United States

  • Evidera (PPD)Morrisville, United StatesContact: Marielle Bassell, BATaking people

About the trial

What the trial wants to find out

The WAKIX (pitolisant) Pregnancy Registry is a US-based, prospective, observational cohort study designed to evaluate the association between pitolisant exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.

The 5 groups in the trial

  • Pitolisant-exposed participants with narcolepsy

    Pregnant women with a diagnosis of narcolepsy who are exposed to pitolisant at any time during pregnancy

    Treatment: Pitolisant

  • Unexposed participants with narcolepsy

    Pregnant women with a diagnosis of narcolepsy who are not exposed to pitolisant or a comparator product at any time during pregnancy

  • Comparator-exposed participants with narcolepsy

    Pregnant women with a diagnosis of narcolepsy who are not exposed to pitolisant at any time during pregnancy but who are exposed to comparator products at any time during pregnancy

    Treatment: Comparator Products

  • Pitolisant-exposed participants without narcolepsy

    Pregnant women without a diagnosis of narcolepsy who are exposed to pitolisant at any time during pregnancy

    Treatment: Pitolisant

  • Comparator-exposed participants without narcolepsy

    Pregnant women without a diagnosis of narcolepsy who are not exposed to pitolisant at any time during pregnancy but who are exposed to a comparator product at any time during pregnancy

    Treatment: Comparator Products

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
WAKIX® (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring
Plain-language title
Follows pregnant women taking pitolisant for narcolepsy and their babiesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
12 June 2026